Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Queueing Can Aid Healthcare in the Fight Against Concurrent Flu and COVID-19 Care

This flu season is unlike any we’ve ever seen – occurring at the same time as a global pandemic, it’s straining the healthcare system in the United States and beyond in new and impactful ways. COVID-19’s more than 22 million cases in the U.S. have resulted in nearly 400,000 deaths, adding to flu deaths that…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
How Queueing Can Aid Healthcare in the Fight Against Concurrent Flu and COVID-19 Care

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

This flu season is unlike any we’ve ever seen – occurring at the same time as a global pandemic, it’s straining the healthcare system in the United States and beyond in new and impactful ways.

COVID-19’s more than 22 million cases in the U.S. have resulted in nearly 400,000 deaths, adding to flu deaths that number in the tens of thousands each year. The sheer number of COVID-19 cases during a period already flooded with millions of flu cases adds up to serious pressure on the country’s healthcare system to find ways to handle never-before-seen droves of patients without a significant increase in capacity.

There are a number of strategies that can help the U.S. healthcare system more effectively keep pace with these staggering numbers, though one might be being overlooked – queueing.

Queuing solutions and lobby management can help healthcare facilities ease some of their mounting burden in a number of ways, bringing efficiency and order to what continues to be a chaotic time in healthcare. Let’s take a look at how.

How Queueing Solutions Bring Relief for Strained Healthcare Facilities

Queueing, lobby management and hospital management solutions help drive efficiencies in healthcare in a number of ways.

  • Empower better patient management.

Particularly in today’s climate, lobbies can’t afford to be overcrowded, and physicians can’t afford to be running from place to place in their efforts to treat a wide range of patients.

With a queueing solution, practices can get clear insights into wait times, important KPIs, and employee proficiency, and the ease of scheduling that comes along with a queueing solution ensures that patients are booked for the appropriate amount of time, are always informed about when they’ll be seen, and receive optimal care.

The patient’s experience should be effective and efficient, and managing scheduling with a queueing solution that empowers mobile-friendly options and sign-in, elevated privacy, SMS updates, wait-time transparency and wait-anywhere functionality, and more can help deliver that experience.

  • Reduce the burden on staff and associated strain and burnout.

When a practice or hospital is more efficient, its staff is less frustrated, tired and strained. Queueing systems don’t just serve patients – they help practices run more efficiently from top to bottom, helping staff avoid tedious manual entry and tasks and place their attention where it matters – on patients.

This relief of the growing burden on healthcare professionals is even more critical this flu season, when concurrent cases of the flu and COVID-19 are making it more difficult than ever to remain focused, engaged and productive.

  • Improve patient outcomes and satisfaction.

When patients can sign up and sign in from anywhere, get real-time insight into when they’ll be seen, and work with a doctor engaged and ready to go instead of strained and ragged, satisfaction skyrockets.

Better yet, so do patient outcomes.

The benefits of a queueing system are all aimed at one goal – delivering better outcomes to the patients a practice or hospital sees. The robust data collected by queueing systems and associated patient experience surveys ensure that there’s a consistent feedback loop of actionable insights continuing to propel care forward, and the entire healthcare ecosystem benefits from the added efficiencies queueing brings.

Queueing solutions in other sectors of society also benefit the healthcare system by better enforcing social distancing and other precautions, potentially reducing the overall number of COVID-19 cases that will eventually end up straining that healthcare infrastructure.

Today’s patients want availability, mobility, ease of use and transparency, and the right queueing system allows healthcare practices and hospitals to provide all of those key benefits.

To learn more about how NEMO-Q is aiding healthcare in the fight against the flu and the COVID-19 pandemic, visit nemo-q.com/healthcare/

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Direct-to-consumer telehealth raises spending, even as ASC investment surges

Direct-to-consumer telehealth raises spending, even as ASC investment surges

A Health Affairs analysis of commercial claims data (2011–13) found 12% of direct-to-consumer telehealth visits replaced visits to other providers and 88% represented new utilization, with net annual spending on acute respiratory illness increasing $45 per telehealth user. Separately, MobiHealthNews reported on August 31, 2026, via a HIMSSCast episode, that Erik Tellefson of Capital One said ambulatory surgery centers “represent one of the clearest growth structures in American healthcare.”

  • 01The most actionable benchmark for finance teams evaluating DTC telehealth is substitution rate, not visit growth. Health Affairs measured 12% substitution and 88% new utilization in commercial claims for acute respiratory illness.
  • 02The $45 per-user net annual spend increase in the Health Affairs analysis is small enough to hide in PMPM reporting but large enough to matter at scale, and it should be stress-tested against virtual-visit eligibility rules and repeat-use patterns.

Sep 2, 2026

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

  • 01HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.
  • 02Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.
  • 03HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Sep 2, 2026

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512